Evidence map›Paper›PMID 35815289›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2022

The Experimental Exploration of TCM Theory "Treating the Same Disease with Different Approaches" on an Ulcerative Colitis Model.

Lulu Ni, Lingzhong Kong, Yajun Tang, Yangfan Nie, Xinyue Wang, Xue Yang, Li Zhu, Shan Jing

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 1 country.

Lulu NiDepartment of Basic Medicine, Jiangnan University, Wuxi, Jiangsu 214122, China.
Lingzhong KongDepartment of Rehabilitation Acupuncture Medicine, Bozhou People's Hospital, Bozhou, Anhui 236800, China.
Yajun TangDepartment of Gastroenterology, Ningbo Municipal Hospital of Traditional Chinese Medicine, Ningbo, Zhejiang 315016, China.
Yangfan NieDepartment of Basic Medicine, Jiangnan University, Wuxi, Jiangsu 214122, China.
Xinyue WangDepartment of Internal Medicine of TCM, Dong-Zhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China.
Xue YangDepartment of Internal Medicine of TCM, Hennan University of Traditional Chinese Medicine, Zhengzhou, Henan 450003, China.
Li ZhuDepartment of Internal Medicine of TCM, Dong-Zhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China.
Shan JingDepartment of Internal Medicine of TCM, Nantong Hospital of Traditional Chinese Medicine, Nanjing University of Chinese Medicine, Nantong, Jiangsu 226000, China.ORCID https://orcid.org/0000-0001-9721-8839
Beijing University of Chinese Medicine · CNJiangnan University · CNBozhou People's Hospital · CNHenan University of Traditional Chinese Medicine · CNNanjing University of Chinese Medicine · CNNingbo Municipal People's Government · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is a relationship between lung injury and ulcerative colitis. Currently, traditional Chinese medicine (Huangqi Jiegeng (HQJGD) and Huangqi Huanglian decoctions (HQHLD)) is commonly used for UC-related lung injury; however, the mechanisms of these drugs remain unclear. In this study, UC models were established with the mucous membrane of colon allergize combined with TNBS-alcohol enteroclysis for 4 weeks. The pathological changes in the lung, intestine, liver, and kidney were observed; cytokines, chemokines, and adhesion molecules in lung tissue were detected in order to explore the immunological mechanism of UC-related lung injury and the intervention mechanism of traditional Chinese medicine in treating the lung and intestine in the immune-TNBS-ethanol rat model. Histology examinations demonstrated evident pathological changes in the lungs and intestines of the model groups. Furthermore, all groups treated with TCMs demonstrated reduced expressions of toll-like receptor 4, nuclear factor kappa-B, and macrophage migration inhibitory factor. Additionally, radioimmunoassay and immunohistochemistry showed tumor necrosis factor-

Identifiers

PMID35815289
PMCPMC9262511
OpenAlexW4283751062

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.